Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Depreciation & Amortization (CF): 2018-2024

Historic Depreciation & Amortization (CF) for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $833,000.

  • Gossamer Bio's Depreciation & Amortization (CF) fell 97.00% to $6,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $126,000, marking a year-over-year decrease of 88.01%. This contributed to the annual value of $833,000 for FY2024, which is 48.16% down from last year.
  • Gossamer Bio's Depreciation & Amortization (CF) amounted to $833,000 in FY2024, which was down 48.16% from $1.6 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Depreciation & Amortization (CF) ranged from a high of $1.8 million in FY2022 and a low of $833,000 during FY2024.
  • For the 3-year period, Gossamer Bio's Depreciation & Amortization (CF) averaged around $1.4 million, with its median value being $1.6 million (2023).
  • Per our database at Business Quant, Gossamer Bio's Depreciation & Amortization (CF) skyrocketed by 53.65% in 2020 and then slumped by 48.16% in 2024.
  • Over the past 5 years, Gossamer Bio's Depreciation & Amortization (CF) (Yearly) stood at $1.4 million in 2020, then grew by 23.49% to $1.7 million in 2021, then climbed by 5.29% to $1.8 million in 2022, then decreased by 12.28% to $1.6 million in 2023, then slumped by 48.16% to $833,000 in 2024.